GEVA
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
GEVA
Delisted
GEVA was delisted on the 22nd of June, 2015.
130 hedge funds and large institutions have $3.89B invested in SYNAGEVA BIOPHARMA CORP COM STK (DE) in 2015 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 56 increasing their positions, 41 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
130
Holders Change
+4
Holders Change %
+3.17%
% of All Funds
3.47%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
23
Increased
56
Reduced
41
Closed
19
Calls
$21.7M
Puts
$68.8M
Net Calls
-$47.1M
Net Calls Change
-$44M
Top Buyers
Top Sellers
| 1 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
-$58.7M |
| 2 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$27.4M |
| 3 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
-$10.2M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$9.91M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$7.58M |
